For T2D-PD, proteins such as TLN2 and SAMP are identified as biomarkers within the merged dataset's tree, with these markers also proving pivotal in our dataset's analysis (see Fig. 6C). This evidence concerns the gene XPNPEP1 and type 2 diabetes mellitus.